Araştırma Alanları
Avesis Araştırma Alanları:
Tıp, Dahili Tıp Bilimleri, İç Hastalıkları, Onkoloji, Sağlık Bilimleri
WoS Araştırma Alanları:
Klinik Tıp (Med), Klinik Tıp, Onkoloji
Scopus Araştırma Alanları:
Onkoloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Eğitim Bilgileri
2022 - Devam Ediyor
2022 - Devam EdiyorDoktora
İstinye Üniversitesi, Lisansüstü Eğitim Enstitüsü, Moleküler Onkoloji (DR), Türkiye
2017 - 2020
2017 - 2020Tıpta Yandal Uzmanlık
İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
2012 - 2016
2012 - 2016Tıpta Uzmanlık
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Türkiye
2005 - 2011
2005 - 2011Lisans
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, İngilizce Tıp, Türkiye
Yaptığı Tezler
2016
2016Tıpta Uzmanlık
MEME KANSERİNDE NEOADJUVAN KEMOTERAPİ YANITINI
PREDİKTE EDEN PATOLOJİK FAKTÖRLER
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakultesi, İç Hastalıkları Anabilim Dalı
2016
2016Tıpta Uzmanlık
Meme kanserinde neoadjuvan kemoterapi yanıtını predikte eden patolojik faktörler
İstanbul Üniversitesi-Cerrahpaşa, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Yabancı Diller
B1 Orta
B1 Ortaİngilizce
Sertifika, Kurs ve Eğitimler
2018
2018PSİKOONKOLOJİ 2. DÜZEY KLİNİSYEN EĞİTİMİ
Eğitim Yönetimi ve Planlama
PSİKONET-UZM. PSİKOLOG ESRA SAVAŞ KAPLAN BİREYSEL EĞİTİMİ
2017
2017AİLE DANIŞMANLIĞI
Eğitim Yönetimi ve Planlama
ULUDAĞ ÜNİVERSİTESİ-UZAKTAN EĞİTİM
2017
2017İMMUNOONKOLOJİ KURSU
Sağlık ve Tıp
TÜRK TIBBİ ONKOLOJİ DERNEĞİ
2017
2017PSİKOONKOLOJİ 1. DÜZEY KLİNİSYEN EĞİTİMİ
Eğitim Yönetimi ve Planlama
PSİKONET-UZM. PSİKOLOG ESRA SAVAŞ KAPLAN BİREYSEL EĞİTİMİ
Akademik Ünvanlar / Görevler
2024 - Devam Ediyor
2024 - Devam EdiyorDr. Öğr. Üyesi
İstanbul Üniversitesi, Onkoloji Enstitüsü, Klinik Onkoloji Ana Bilim Dalı
2023 - 2024
2023 - 2024Doç. Dr.
İstanbul Bilim Üniversitesi
2017 - 2020
2017 - 2020Araştırma Görevlisi
İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2012 - 2016
2012 - 2016Araştırma Görevlisi
İstanbul Üniversitesi-Cerrahpaşa, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Makaleler
Tümü (69)
SCI-E, SSCI, AHCI (56)
SCI-E, SSCI, AHCI, ESCI (63)
ESCI (7)
Scopus (66)
TRDizin (12)
Diğer Yayınlar (1)
2026
20261. Serum miR-181a-5p, miR-214-3p, and miR-223-3p in epithelial ovarian cancer
BAŞPINAR Ş. N., Kucukgergin C., Aydin A. F., Minareci Y., Topuz S., Sozen H., et al.
Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)
2026
20262. Durable complete response after a single cycle of pembrolizumab-based chemoimmunotherapy in metastatic squamous cell lung cancer: a case report
Çokgezer S., AK N.
Discover Oncology
, cilt.17, sa.1, 2026 (SCI-Expanded, Scopus)
2026
20263. Real-World Survival Outcomes of Adjuvant Chemotherapy Versus Endocrine Therapy Alone in Hormone Receptor- Positive, Human Epidermal Growth Factor Receptor 2-Negative Invasive Lobular Carcinoma
Çokgezer S., şenkal m., Aysel A., Topuz S., Saip P., Ak N.
Cerrahpaşa Medical Journal
, sa.1, ss.1, 2026 (TRDizin)
2026
20264. Prognostic Impact of ABO/Rh Blood Group–Systemic Inflammation Indices Interactions in Small-Cell Lung Cancer
Yıldız A., ZENGİN B. A., Mildanoglu M. M., ULUFER B., BİLİCİ A., AK N.
Biomedicines
, cilt.14, sa.5, 2026 (SCI-Expanded, Scopus)
2026
20265. CT-based radiomics for predicting PD-L1 expression status in non-small cell lung cancer using a hybrid machine learning model
Durmaz M., Emec M., KIZILDAĞ YIRGIN İ., ILGIN C., Kaval G., Bunul I., et al.
Clinical Imaging
, cilt.132, 2026 (SCI-Expanded, Scopus)
2026
20266. Oncological Outcomes of Breast-Conserving Surgery Versus Mastectomy in Invasive Lobular Breast Cancer: A Single-Center Retrospective Study
ÇOKGEZER S., Safaraliyeva A., Topuz S., Şenkal M., AK N., TAŞTEKİN D., et al.
Medicina (Lithuania) , cilt.62, sa.4, 2026 (SCI-Expanded, Scopus)
2026
20267. Prognostic Role of Endocan and Platelet-Derived Growth Factor Isoforms in Metastatic Colorectal Cancer
Yildiz A., Ahmed M. A., Azizy A., Çokgezer S., Ulufer B., Soydinc H., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
, cilt.27, sa.6, 2026 (SCI-Expanded, Scopus)
2026
20268. Evaluating Comorbidity Scores in Geriatric Ovarian Cancer: A Retrospective Cohort Analysis
ÇOKGEZER S., AK N., Senkal M., Safaraliyeva A., TAŞTEKİN D., SAİP P. M.
Medicina (Lithuania)
, cilt.62, sa.1, 2026 (SCI-Expanded, Scopus)
2025
20259. Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival
Ellez H. İ., SEMİZ H. S., EKİNCİ F., ERDOĞAN A. P., Kuş F., Karataş F., et al.
Journal of Bone Oncology , cilt.55, 2025 (SCI-Expanded, Scopus)
2025
202510. Association Between Adipose Tissue Distribution and Survival in Recurrent Ovarian Cancer Patients Treated With Anti-VEGF Therapy: A Retrospective CT-Based Analysis
Cokgezer S., Senkal M., Safaraliyeva A., Kose H., KIZILDAĞ YIRGIN İ., SAİP P. M., et al.
Journal of Obstetrics and Gynaecology Research , cilt.51, sa.11, 2025 (SCI-Expanded, Scopus)
2025
202511. Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program
ŞENDUR M. A. N., Hizal M., Cakar B., AKTEPE O. H., Eraslan E., ARIK Z., et al.
BMC CANCER , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)
2025
202512. Impact of Treatment Duration in First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Multicenter Real-World Retrospective Study
Baser M. N., Demir B., Serin Ozel G., Dogu G. G., Karakaya S., UGAR M., et al.
Medicina (Lithuania)
, cilt.61, sa.7, 2025 (SCI-Expanded)
2025
202513. Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial.
Özkurt E., Ordu C., Özmen T., Ilgun A. S., Soybir G., Celebi F., et al.
World journal of surgery
, 2025 (SCI-Expanded)
2025
202514. Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis
Kalkan N., Ucar G., Esen S., Bardakci M., Aydin S., Celebi A., et al.
NIGERIAN JOURNAL OF CLINICAL PRACTICE
, cilt.28, sa.2, ss.212-218, 2025 (SCI-Expanded, Scopus)
2025
202515. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study
Dülgar Ö., Türker S., Başaran G., Araz M., Sümbül A. T., Çağlayan D., et al.
Journal of Chemotherapy
, cilt.37, sa.4, ss.334-340, 2025 (SCI-Expanded, Scopus)
2024
202416. Outcomes of reconstructive techniques in breast cancer using BCCT. core software
Kurt S., İlgün A. S., Özkurt E., Soybir G., Alço G., Ünal Ç., et al.
World Journal of Surgical Oncology , cilt.22, sa.1, 2024 (SCI-Expanded, Scopus)
2024
202417. Prognostic Value of p16INK4A and Ki67 Co-expression in Patients with Vaginal Intraepithelial Neoplasia
Minareci Y., AK N., Bayram A., Tosun O. A., Murdan R., Onder S., et al.
INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY , cilt.22, sa.2, 2024 (ESCI)
2024
202418. The evaluation of miR-1181 and miR-4314 as serum microRNA biomarkers for epithelial ovarian cancer diagnosis and prognosis.
Minareci Y., Ak N., Sozen H., Tosun O. A., Kucukgergin C., Aydin F., et al.
Molecular biology reports
, cilt.51, sa.1, ss.515, 2024 (SCI-Expanded, Scopus)
2024
202419. The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy
Tapan T. K., Çelebi F., Yaghouti K., Aǧaçayak F., Ilgün S., Soybir G., et al.
European Journal of Breast Health
, cilt.20, sa.2, ss.117-121, 2024 (ESCI, Scopus, TRDizin)
2024
202420. The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients
Ak N., Tuz Z., Aydin E., Ferhatoğlu F., SARI M., Paksoy N., et al.
Turkish Journal of Medical Sciences
, cilt.54, sa.1, ss.229-238, 2024 (SCI-Expanded, Scopus, TRDizin)
2024
202421. The Effect of Adjuvant Therapies for Recurrence in Stage I Breast Cancer Patients: A Single Centre Experience
Doğan İ., Khanmammadov N., Aydin E., PAKSOY N., Ferhatoğlu F., AK N., et al.
Turk Onkoloji Dergisi , cilt.39, sa.3, ss.257-264, 2024 (ESCI, Scopus, TRDizin)
2023
202322. Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients
DOĞAN İ., Aydin E., KHANMAMMADOV N., Paksoy N., Ferhatoğlu F., AK N., et al.
Journal of Cancer Research and Clinical Oncology
, cilt.149, sa.16, ss.14833-14841, 2023 (SCI-Expanded, Scopus)
2023
202323. Autoimmune hemolytic anemia associated with clear cell renal carcinoma: A case report
Güven S., Ak N.
Journal of Current Hematology & Oncology Research , cilt.3, sa.1, ss.102-103, 2023 (Hakemli Dergi)
2023
202324. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
Ünal Ç., AZİZY A., KARABULUT S., TAŞTEKİN D., AKYILDIZ A., YAŞAR S., et al.
The oncologist
, cilt.28, sa.10, ss.875-884, 2023 (SCI-Expanded, Scopus)
2023
202325. MICRORNA 1181 AND 4314 AS PROMISING BIOMARKERS FOR EPITHELIAL OVARIAN CANCER DIAGNOSIS AND PROGNOSIS
MİNARECİ Y., AK N., SÖZEN H., Tosun O. A., KÜÇÜKGERGİN C., AYDIN F., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 2023 (SCI-Expanded, Scopus)
2023
202326. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)
Hizal M., Bilgin B., Paksoy N., Atci M. M., KAHRAMAN S., Kilickap S., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
, cilt.149, sa.8, ss.4141-4148, 2023 (SCI-Expanded, Scopus)
2023
202327. Central nervous system metastasis in gynecologic cancers: Seeking the prognostic factors
Minareci Y., AK N., Tosun O. A., Sozen H., SAİP P. M., Topuz S., et al.
Journal of Cancer Research and Therapeutics , cilt.19, 2023 (SCI-Expanded, Scopus)
2023
202328. Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated with A Combination of Lapatinib and Capecitabine
DOĞAN İ., Paksoy N., AK N., VATANSEVER S., Saip P., AYDINER A.
European Journal of Breast Health
, cilt.19, sa.2, ss.128-133, 2023 (Scopus, TRDizin)
2023
202329. Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study
BAŞOĞLU TÜYLÜ T., Sakin A., Erol C., Ozden E., ÇABUK D., Cilbir E., et al.
JOURNAL OF CHEMOTHERAPY
, cilt.35, sa.2, ss.142-149, 2023 (SCI-Expanded, Scopus)
2023
202330. Clinicopathologic characteristics and prognostic factors in patients with male breast cancer: A single tertiary center experience
Dogan I., AYDIN E., AK N., ÖZKURT S., İBİŞ K., ŞÜKRÜOĞLU ERDOĞAN Ö., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.19, sa.7, ss.1887-1892, 2023 (SCI-Expanded, Scopus)
2023
202331. MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification
Unal C., Ozmen T., Ilgun A. S., Ordu C., Ozkurt E., AK N., et al.
BREAST CANCER-TARGETS AND THERAPY
, cilt.15, ss.659-669, 2023 (SCI-Expanded, Scopus)
2023
202332. Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital
FERHATOĞLU F., Kapağan T., Paksoy N., Ak N., Medetalibeyoğlu A., Şenkal N., et al.
Turk Onkoloji Dergisi
, cilt.38, sa.1, ss.82-91, 2023 (ESCI, Scopus, TRDizin)
2022
202233. Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study
PAKSOY N., KHANMAMMADOV N., DOĞAN İ., FERHATOĞLU F., YILDIZ A., AK N., et al.
Medicine (United States)
, cilt.101, sa.45, 2022 (SCI-Expanded, Scopus)
2022
202234. The Predictive Importance of Body-Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
Emirzeoglu L., Arici S., Sahin A. B., Ocak B., Ak N., Ay S., et al.
BREAST CARE
, 2022 (SCI-Expanded, Scopus)
2022
202235. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study
Hizal M., Bilgin B., Paksoy N., Kilickap S., Atci M. M., KAHRAMAN S., et al.
FUTURE ONCOLOGY
, cilt.18, ss.2573-2582, 2022 (SCI-Expanded, Scopus)
2022
202236. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
Hizal M., Bilgin B., Paksoy N., Acikgoz O., Sezer A., Gurbuz M., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
, cilt.148, sa.6, ss.1501-1508, 2022 (SCI-Expanded, Scopus)
2022
202237. Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination.
Dogan I., Paksoy N., Ak N., Vatansever S., Saip P., Aydiner A.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.40, sa.16, 2022 (SCI-Expanded, Scopus)
2022
202238. Recurrent autoimmune encephalitis related to immune checkpoint inhibitors
Ser M. H., Samanci N. S., Naziye A. K., Aydiner A., Ozkara C.
EPILEPTIC DISORDERS , cilt.24, sa.3, ss.609-613, 2022 (SCI-Expanded)
2022
202239. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study
Cil I., Kucukarda A., Atci M. M., Secmeler S., Paksoy N., Ferhatoglu F., et al.
TUMORI JOURNAL
, cilt.108, sa.1, ss.19-25, 2022 (SCI-Expanded, Scopus)
2022
202240. Prolongation of Neoadjuvant Chemotherapy before Surgery: Seeking the Optimal Number of Cycles in Serous Ovarian Cancer
Minareci Y., Sozen H., Ak N., Tosun O. A., Saip P., Salihoglu M. Y., et al.
CHEMOTHERAPY
, cilt.67, ss.1-11, 2022 (SCI-Expanded, Scopus)
2022
202241. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer
Esen S. A., Ergun Y., Erol C., Arikan R., Er M. M., Atci M. M., et al.
Bosnian Journal of Basic Medical Sciences , cilt.22, sa.5, ss.818-825, 2022 (SCI-Expanded, Scopus)
2022
202242. Does nutritional status affect treatment tolerability, chemotherapy response and survival in metastatic gastric cancer patients? Results of a prospective multicenter study in Turkey
Karabulut S., DOĞAN İ., USUL AFŞAR Ç., Karabulut M., Ak N., Duran A., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.28, sa.1, ss.127-134, 2022 (SCI-Expanded, Scopus)
2022
202243. Predictors of high-grade residual disease after repeat conization in patients with positive surgical margins
Minareci Y., AK N., Tosun O. A., Sozen H., Disci R., Topuz S., et al.
Ginekologia polska , cilt.93, sa.12, ss.962-967, 2022 (Scopus)
2022
202244. Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.
Paksoy N., Erdem S., Karaca M., Ak N., Pehlivan M., Yirgin İ., et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , cilt.28, sa.1, ss.215-221, 2022 (SCI-Expanded, Scopus)
2021
202145. Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer
Ak N., Vatansever S.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
, cilt.46, sa.6, ss.1787-1791, 2021 (SCI-Expanded, Scopus)
2021
202146. Clinicopathological and Prognostic Features of 67 Cases with Pulmonary Sarcomatoid Carcinoma: An 18-Year Single-Centre Experience
Ferhatoglu F., Amirov F., Ozkan B., Kara M., Toker A., Ak N., et al.
ONCOLOGY RESEARCH AND TREATMENT
, sa.11, ss.590-600, 2021 (SCI-Expanded, Scopus)
2021
202147. Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center
Ak N., Toker A., Kara M., Ozkan B., Ulker M., Kaba E., et al.
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
, cilt.29, sa.4, ss.487-495, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202148. Nivolumab treatment for metastatic thymic epithelial tumors.
Ak N., Aydiner A.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , cilt.27, ss.1710-1715, 2021 (SCI-Expanded, Scopus)
2021
202149. Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment
Karanlik H., CABIOĞLU N., Oprea A. L., ÖZGÜR İ., AK N., AYDINER A., et al.
BREAST CARE
, cilt.16, sa.5, ss.468-474, 2021 (SCI-Expanded, Scopus)
2021
202150. Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
Oner G., Onder S., Karatay H., Ak N., Tukenmez M., Muslumanoglu M., et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY
, cilt.19, sa.1, 2021 (SCI-Expanded, Scopus)
2021
202151. Skeletal system as a rare metastatic site in patients with ovarian carcinoma
Ak N., Minareci Y., Saip P.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
, cilt.31, sa.8, ss.1125-1131, 2021 (SCI-Expanded, Scopus)
2021
202152. Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors.
Ferhatoglu F., Paksoy N., Dogan I., Ak N., Pehlivan M., Ekenel M., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.15, 2021 (SCI-Expanded, Scopus)
2021
202153. Long-term outcomes and predictors of recurrence in patients with early-stage node negative breast cancer.
Dogan I., Aydin E., Paksoy N., Ferhatoglu F., Ak N., Ibis K., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.39, sa.15, 2021 (SCI-Expanded, Scopus)
2021
202154. The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study
Ak N., Ozkan B., Yenigun M. B., Yilmazbayhan D., Toker A., Ferhatoglu F., et al.
JOURNAL OF BUON
, cilt.26, sa.3, ss.819-829, 2021 (SCI-Expanded, Scopus)
2021
202155. Malignancy Algorithms in The Preoperative Assessment of Suspicious Adnexal Masses During Pregnancy
MINARECI Y., TOSUN Ö., Ak N., SÖZEN H., TOPUZ S., SALIHOGLU M. Y.
Kocaeli Tıp Dergisi
, cilt.10, sa.3, ss.217-224, 2021 (Hakemli Dergi)
2021
202156. Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer
AK N., PAKSOY N., VELİDEDEOĞLU M., TURNA Z. H., DEMİRELLİ F. H.
Journal of oncological sciences , cilt.7, sa.2, ss.42-49, 2021 (Scopus, TRDizin)
2021
202157. "Door to Treatment" Outcomes of Cancer Patients during the COVID-19 Pandemic
Ak N., Vatansever S.
CHEMOTHERAPY
, cilt.65, sa.5-6, ss.141-146, 2021 (SCI-Expanded, Scopus)
2021
202158. Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer?
Celik E., Kizildag Yirgin I., Goksever Celik H., Engin G., Sozen H., Ak N., et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
, cilt.47, sa.2, ss.560-569, 2021 (SCI-Expanded, Scopus)
2021
202159. Effect of Astragalus Membranaceus on Patients with Metastatic Non-Small Cell Lung Cancer: A Retrospective Cohort Study
Ak N., Ciftci R., Cabioglu N., Aydiner A.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, cilt.36, sa.2, ss.215-221, 2021 (ESCI, Scopus, TRDizin)
2021
202160. Nectin-2 and Nectin-4 Adhesion Molecules in Patients with Breast Cancer
Ak N., Serilmez M., Ucuncu M. Z., Bademler S., Vatansever S.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, cilt.36, sa.2, ss.165-170, 2021 (ESCI, Scopus, TRDizin)
2021
202161. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
Bahceci A., PAYDAŞ S., Ak N., Ferhatoglu F., Saip P. M., SEYDAOĞLU G., et al.
CANCER INVESTIGATION
, cilt.39, sa.6-7, ss.473-481, 2021 (SCI-Expanded, Scopus)
2021
202162. Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma
Naziye A. K., Paksoy N., Ferhatoglu F., Aydin E., Dogan I., Bektas E., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.36, ss.438-445, 2021 (ESCI)
2020
202063. Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
Alkan A., Yasar A., Guc Z. G., Gurbuz M., BAŞOĞLU TÜYLÜ T., SEZGİN GÖKSU S., et al.
EUROPEAN JOURNAL OF CANCER CARE
, cilt.29, sa.6, 2020 (SCI-Expanded, SSCI, Scopus)
2020
202064. Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels
Tüzer C., Sarı M., Aktaş Ç., Ak N., Büyüköztürk S., Çolakoğlu B., et al.
ALLERGY , cilt.75, sa.11, ss.2942-2946, 2020 (SCI-Expanded, Scopus)
2019
201965. IS CHEMOTHERAPY BETTER FOR EARLY STAGE HIGH RISK HISTOLOGIC TYPES OF ENDOMETRIAL CANCER
ÇELİK E. G., AK N., SÖZEN H., SAİP P. M., TOPUZ S.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
, cilt.29, 2019 (SCI-Expanded, Scopus)
2019
201966. The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study
Eralp Y., Ak N., Yilmazbayhan D., Ozkan B., Ferhatoglu F., Demirkazik A., et al.
JOURNAL OF THORACIC ONCOLOGY , cilt.14, sa.10, 2019 (SCI-Expanded, Scopus)
2019
201967. Outcomes of Thymoma and Determinants of Survival: 16 Years Experience of a Tertiary Cancer Center
Ak N., Toker A., Bayraktar S., Ozkan B., Ülker M. B. C., Dagoglu N., et al.
JOURNAL OF THORACIC ONCOLOGY , sa.10, 2019 (SCI-Expanded, Scopus)
2019
201968. Feasibilty of sentinel lymph node biopsy in patients with node-positive inflammatory breast cancer who responded to neoadjuvant systemic treatment
OPREA A. -., Ak N., Saip P., Onder S., Bademler S., Gulluoglu B. M., et al.
BREAST
, cilt.44, 2019 (SCI-Expanded)
2019
201969. Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.
Keskin S., Kucucuk S., Ak N., ATALAR B., Sari M., Sozen H., et al.
Oncology research and treatment
, cilt.42, sa.3, ss.101-106, 2019 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2026
20261. Serum miR-181-5p, miR-214-3p, and miR-223-3p expression in epithelial ovarian cancer.
AK N., Baspinar S. N., KÜÇÜKGERGİN C., Minareci Y., Sozen H., TOPUZ S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2026, cilt.44, (Özet Bildiri)
2025
20252. Erken Evre Meme Kanserinde Perkütan Kriyoablasyon: İlk Deneyim ve Erken Dönem Sonuçlar
Kızıldağ Yırgın İ., Çelik L., Cömert Bozkurt R. G., Kılıç B., Yılmaz C., İbiş K., et al.
18. Ulusal Meme Hastalıkları Kongresi, İskele, Kıbrıs (Kktc), 27 - 30 Kasım 2025, ss.96-99, (Özet Bildiri)
2025
20253. Cerrahi Sonrası İntrahepatik Kolanjiyokarsinom Nüksünü Etkileyen Faktörler: Refere BirMerkezin 25 Yıllık Deneyimi
Serin K. R., Şal O., Göksoy B., Uzunyolcu G., Berker N., Büyük M., et al.
17. Türk HPB Cerrahi Kongresi, Antalya, Türkiye, 29 Ekim - 01 Kasım 2025, ss.267, (Özet Bildiri)
2023
20234. MICRORNA 1181 AND 4314 AS PROMISING BIOMARKERS FOR EPITHELIAL OVARIAN CANCER DIAGNOSIS AND PROGNOSIS
Minareci Y., Ak N., Sözen H., Tosun Ö., Küçükgergin C., Aydın A. F., et al.
ESGO 2023 European Congress on Gynaecological Oncology, İstanbul, Türkiye, 28 Eylül - 01 Ekim 2023, cilt.33, ss.242, (Özet Bildiri)
2021
20215. Long-term outcomes and predictors of recurrence in patients with early-stage node negative breast cancer
DOĞAN İ., Aydın E., PAKSOY N., FERHATOĞLU F., AK N., İBİŞ K., et al.
ASCO 2021, Amerika Birleşik Devletleri, 04 Haziran 2021, (Özet Bildiri)
2020
20206. Clinicopathologic features and prognostic factors in male breast cancer: A single centre experience
DOĞAN İ., AYDIN E. M., AK N., İBİŞ K., Sukruoglu Ö., Erciyas S., et al.
ESMO Asia Virtual Congress, ELECTR NETWORK, 20 - 22 Kasım 2020, cilt.31, (Özet Bildiri)
2019
20197. Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study
Karabulut S., Dogan I., Ak N., Afsar C. U., Karabulut M., Tastekin D.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, ss.305, (Özet Bildiri)
2019
20198. Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study
AK N.
European Society for Medical Oncology Congress 2019, Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, ss.424-430, (Özet Bildiri)
2019
20199. THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY
AK N.
World Conferrence of Lung Cancer 2019, Barcelona, İspanya, 7 - 10 Eylül 2019, ss.933-934, (Özet Bildiri)
2019
201910. OUTCOMES OF THYMOMA AND DETERMINANTS OF SURVIVAL: 16 YEARS EXPERIENCE OF A TERTIARY CANCER CENTER
AK N.
World Conferrence of Lung Cancer, Barcelona, İspanya, 7 - 10 Eylül 2019, ss.1095-1096, (Özet Bildiri)
2019
201911. Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels
Tuzer O. C., Sari M., Aktas E., Ak N., Buyukozturk S., Colakoglu B., et al.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, cilt.74, ss.737-738, (Özet Bildiri)
2019
201912. Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels
TÜZER C., SARI M., ÇETİN E., AK N., BÜYÜKÖZTÜRK S., ÇOLAKOĞLU B., et al.
European Academy of Allergy and Clinical Immunology (EAACI) 2019, 1 - 05 Haziran 2019, ss.150, (Özet Bildiri)
2019
201913. Significance of adiposity in endometrial cancer prognosis.
KIZILDAĞ YIRGIN İ., ENGİN G., ÇELİK E., TOPUZ S., AK N., SAİP P.
Türk manyetik rezonans derneği.24.Uluslararası katılımlı yıllık bilimsel toplantısı. 2019, Ankara, Türkiye, 25 - 27 Nisan 2019, (Tam Metin Bildiri)
2018
201814. Platin ile hızlı desensitizasyonun sitokin düzeylerine etkisi P -29
Tüzer Ö. C., Sarı M., ÇETİN E., Ak N., BÜYÜKÖZTÜRK S., ÇOLAKOĞLU B., et al.
XXV. Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Türkiye, 17 - 21 Kasım 2018, ss.111, (Tam Metin Bildiri)
2013
201315. IVIG sonrası akut miyokard enfarktüsü gelişen iki ITP olgusu
BAVUNOĞLU I., EYİCE D., AK N., ELVERDI T., EŞKAZAN A. E., AR M. C., et al.
39. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 23 - 26 Ekim 2013, sa.261, ss.277-278, (Tam Metin Bildiri)
2012
201216. IVIG sonrası akut miyokard enfarktüsü gelişen iki ITP olgusu
BAVUNOĞLU I., EYİCE D., AK N., ELVERDI T., EŞKAZAN A. E., AR M. C., et al.
38. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 31 Ekim - 03 Kasım 2012, sa.261, ss.277-278, (Tam Metin Bildiri)
Kitaplar
2020
20201. Göğüs duvarı tümörlerinde kemoterapi
AK N., Keskin S.
Göğüs duvarı hastalıkları ve cerrahisi, Ali Cevat Kutluk, Soner Gürsoy, Editör, Türkiye Solunum Araştırmaları derneği, ss.209-2013, 2020
2019
20192. Endometrium Kanserleri
AK N.
Klinik Çalışmalarla Onkolojide Hedefli Tedaviler, CİHAN S, GEREDELİ Ç, DEMİR C., Editör, Tıbbi Yayınlar Merkezi, İstanbul, ss.113-122, 2019
2019
20193. Systemic Treatment Drugs/Regimens and Dose Modifications
AK N.
Breast Disease, Aydiner A., Igci A., Soran A., Editör, Springer, Cham, Isviçre, ss.789-801, 2019
2019
20194. Systemic Treatment Drugs/Regimens and Dose Modifications
AK N., AYDINER A.
Breast Disease, Adnan Aydiner, Abdullah Igci, Atilla Soran, Editör, Springer Cham, ss.789-801, 2019
2019
20195. Timus hastalıklarında kemoterapi
AK N., AYDINER A.
Timus hastalıkları ve tedavisi, Dr. Koray Dural, Dr. Berker Özkan, Dr. Berkant Özpolat, Editör, Ankara Nobel Tıp Kitabevleri, Ankara, ss.180-185, 2019
2018
20186. Systemic Treatment Drugs and Regimens
AK N.
Breast Cancer
A Guide to Clinical Practice, Aydiner A, Igci A, Soran A., Editör, Springer International Publishing, Copyright Holder Springer Nature Switzerland Ag, ss.587-608, 2018
2018
20187. Systemic Treatment Drugs and Regimens
AK N., AYDINER A.
Breast Cancer, Adnan Aydiner, Abdullah Igci, Atilla Soran, Editör, Springer Cham, ss.587-608, 2018
Bilimsel Yayınlarda Hakemlikler
Eylül 2019
Eylül 201921st World Congress of Psycho-Oncology /Abstract Reviewer
Diğer Dergiler